Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Association between chromogranin A gene polymorphism and schizophrenia in the Japanese population.

Takahashi N, Ishihara R, Saito S, Maemo N, Aoyama N, Ji X, Miura H, Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Ozaki N, Inada T.

Schizophr Res. 2006 Apr;83(2-3):179-83. Epub 2006 Feb 28.

PMID:
16504480
2.
3.

Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia.

Landén M, Grenfeldt B, Davidsson P, Stridsberg M, Regland B, Gottfries CG, Blennow K.

Eur Neuropsychopharmacol. 1999 Jun;9(4):311-5.

PMID:
10422891
4.

CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin).

Miller C, Kirchmair R, Troger J, Saria A, Fleischhacker WW, Fischer-Colbrie R, Benzer A, Winkler H.

Biol Psychiatry. 1996 Jun 1;39(11):911-8.

PMID:
9162202
5.

CSF chromogranin A-like immunoreactivity in schizophrenia: relationships with REM latency and slow wave sleep.

van Kammen DP, O'Connor DT, Neylan TC, Mouton A, Gurklis JA, Gilbertson MW, Peters JL.

Psychiatry Res. 1992 Apr;42(1):53-63.

PMID:
1603881
6.

CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships.

van Kammen DP, Peters J, Yao J, Neylan T, Beuger M, Pontius E, O'Connor DT.

Schizophr Res. 1991 Dec;6(1):31-9. Erratum in: Schizophr Res 1992 Jul;7(2):199.

PMID:
1723893

Supplemental Content

Loading ...
Support Center